Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference3%
- Check36 days agoChange DetectedSeveral key health-related resources, including MedlinePlus and NIH links, have been removed from the website.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources including links to MedlinePlus, DailyMed, and PubMed, while removing the previous version 2.12.1.SummaryDifference4%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.